POSA28 Reductions in Migraine and Headache Days After Initiating Fremanezumab for Patients with Migraine and Prior Use of Another Monoclonal Antibody Targeting the CGRP Pathway in a US Real-World Setting

Saved in:
Bibliographic Details
Published inValue in health Vol. 25; no. 1; p. S23
Main Authors Driessen, M, Patterson-Lomba, O, Mu, F, Thompson, S, Seminerio, M, Carr, K, Sun, R, Totev, T, Yim, E, Ayyagari, R, Cohen, J
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.01.2022
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2021.11.101